Celldex Therapeutics (CLDX) Competitor Comparison
We are evaluating the key criteria listed to compare Celldex Therapeutics (CLDX) against its competitors in the Biotechnology industry.
Market Capitalization
60 / 368Gross Profits
224 / 278Total Revenue
205 / 300EBITDA
236 / 337Free Cashflow
213 / 352Quick Ratio
100 / 357Earnings per Share
241 / 359Dividend yield
0 / 6Total Cash
137 / 358Performance 3 years
150 / 368Performance 5 years
9 / 368Performance 10 years
233 / 368Linearity 3 years
50 / 368Linearity 5 years
302 / 368Linearity 10 years
238 / 368Total Rank
301 / 368Dividend Rank
80 / 368Valuation Rank
348 / 368Piotroski Rank
360 / 368Muliplier Rank
308 / 368Valuation Rank - CLDX ranking 348 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.